OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452
Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2184-2197
Open Access | Times Cited: 13

Showing 13 citing articles:

Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 16

Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O)
Pia Gattinger, Liubov I. Kozlovskaya, Alexander S. Lunin, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
Georgia Deliyannis, Nicholas A. Gherardin, Chinn Yi Wong, et al.
EBioMedicine (2023) Vol. 92, pp. 104574-104574
Open Access | Times Cited: 13

CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2
Sedthawut Laotee, Methawee Duangkaew, Araya Jivapetthai, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288486-e0288486
Open Access | Times Cited: 8

Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine
David G. Alleva, Eline A. Feitsma, Yester F. Janssen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1

Subunit protein-based vaccines
Vasso Apostolopoulos, Vivek P. Chavda
Elsevier eBooks (2024), pp. 51-62
Closed Access | Times Cited: 1

Aluminum hydroxide and immunostimulatory glycolipid adjuvant combination for enhanced COVID-19 subunit vaccine immunogenicity
Guo-Qing Zou, Ke Li, Cheng Yan, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126145-126145
Closed Access | Times Cited: 1

Integrating 16S rRNA profiling and in-silico analysis for an epitope-based vaccine strategy against Achromobacter xylosoxidans infection
Muhammad Naveed, Ali Hassan, Tariq Aziz, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112287-112287
Closed Access

The Development of Epitope-Based Recombinant Protein Vaccines against SARS-CoV-2
Kanwal Khalid, Hui Xuan Lim, Jung Shan Hwang, et al.
The AAPS Journal (2024) Vol. 26, Iss. 5
Closed Access

Enhancing COVID-19 Vaccine Efficacy: Dual Adjuvant Strategies with TLR7/8 Agonists and Glycolipids
Ke Li, Xing Hu, Xinyi Tu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access

Page 1

Scroll to top